Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD.

Burton JO, Goldsmith DJ, Ruddock N, Shroff R, Wan M.

BMC Nephrol. 2018 Sep 20;19(1):240. doi: 10.1186/s12882-018-1037-8.

2.

Opponent's comments.

Goldsmith DJ.

Nephrol Dial Transplant. 2016 May;31(5):713. doi: 10.1093/ndt/gfw080a. No abstract available.

PMID:
27190393
4.

Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.

Sinha MD, Turner C, Booth CJ, Waller S, Rasmussen P, Goldsmith DJ, Simpson JM.

Pediatr Nephrol. 2015 Oct;30(10):1843-52. doi: 10.1007/s00467-015-3125-3. Epub 2015 May 15.

PMID:
25975437
5.

Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension?

McIntyre CW, Goldsmith DJ.

Kidney Int. 2015 Jun;87(6):1109-15. doi: 10.1038/ki.2015.62. Epub 2015 Apr 8. Review.

PMID:
25853331
6.

Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes.

Humalda JK, Goldsmith DJ, Thadhani R, de Borst MH.

Nephrol Dial Transplant. 2015 Dec;30(12):1988-94. doi: 10.1093/ndt/gfu404. Epub 2015 Jan 20. Review.

7.

The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD).

Goldsmith DJ, Massy ZA, Brandenburg V.

Semin Nephrol. 2014 Nov;34(6):660-8. doi: 10.1016/j.semnephrol.2014.10.002. Review.

PMID:
25498384
8.

Statins in chronic kidney disease and kidney transplantation.

Kassimatis TI, Goldsmith DJ.

Pharmacol Res. 2014 Oct;88:62-73. doi: 10.1016/j.phrs.2014.06.011. Epub 2014 Jul 1. Review.

PMID:
24995940
9.

The trials and tribulations of vitamin D: time for the 'sunshine' vitamin to come in out of the cold - or just more broken promises?

Leckstroem DC, Salzer J, Goldsmith DJ.

Expert Rev Endocrinol Metab. 2014 Jul;9(4):327-344. doi: 10.1586/17446651.2014.908116. Epub 2014 May 12.

PMID:
30763993
10.

Uric acid as a cardiorenal risk factor - ready for prime-time?

Patel KH, Goldsmith DJ.

Int J Clin Pract. 2014 Jul;68(7):796-801. doi: 10.1111/ijcp.12428.

PMID:
24942307
11.

Vitamin D in renal transplantation - from biological mechanisms to clinical benefits.

McGregor R, Li G, Penny H, Lombardi G, Afzali B, Goldsmith DJ.

Am J Transplant. 2014 Jun;14(6):1259-70. doi: 10.1111/ajt.12738. Epub 2014 May 19. Review.

12.

Have we reached the limits for the treatment of diabetic nephropathy?

Hajhosseiny R, Khavandi K, Jivraj N, Mashayekhi S, Goldsmith DJ, Malik RA.

Expert Opin Investig Drugs. 2014 Apr;23(4):511-22. doi: 10.1517/13543784.2014.892580. Epub 2014 Feb 21. Review.

PMID:
24555907
13.

Active vitamin D treatment for reduction of residual proteinuria: a systematic review.

de Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, Goldsmith DJ.

J Am Soc Nephrol. 2013 Nov;24(11):1863-71. doi: 10.1681/ASN.2013030203. Epub 2013 Aug 8. Review.

14.

Prevalence and predictors of abdominal aortic calcification in healthy living kidney donors.

Leckstroem DC, Bhuvanakrishna T, McGrath A, Goldsmith DJ.

Int Urol Nephrol. 2014 Jan;46(1):63-70. doi: 10.1007/s11255-013-0485-0. Epub 2013 Jun 20.

PMID:
23783567
15.

Repeated renal infarction in native and transplanted kidneys due to left ventricular thrombus formation caused by antiphospholipid antibody syndrome.

Scully P, Leckstroem DC, McGrath A, Chambers J, Goldsmith DJ.

Int Med Case Rep J. 2013 Jan 20;6:7-12. doi: 10.2147/IMCRJ.S39301. Print 2013.

16.

Cinacalcet for cardiovascular disease in patients undergoing dialysis.

Goldsmith DJ, Lamb EJ.

N Engl J Med. 2013 May 9;368(19):1843. doi: 10.1056/NEJMc1301247. No abstract available.

PMID:
23656656
17.

FGF23 concentrations measured using "intact" assays similar but not interchangeable.

Sinha MD, Turner C, Goldsmith DJ.

Int Urol Nephrol. 2013 Dec;45(6):1821-3. doi: 10.1007/s11255-013-0451-x. Epub 2013 May 7. No abstract available.

PMID:
23649347
18.

Bone alkaline phosphatase in CKD-mineral bone disorder.

Sardiwal S, Magnusson P, Goldsmith DJ, Lamb EJ.

Am J Kidney Dis. 2013 Oct;62(4):810-22. doi: 10.1053/j.ajkd.2013.02.366. Epub 2013 Apr 23. Review.

PMID:
23623575
19.

Conceptualizing how couples talk about cancer.

Goldsmith DJ, Miller GA.

Health Commun. 2014;29(1):51-63. doi: 10.1080/10410236.2012.717215. Epub 2013 Feb 26.

PMID:
23442190
20.

Rebuttal: the case for routine parathyroid hormone monitoring.

Goldsmith DJ.

Clin J Am Soc Nephrol. 2013 Feb;8(2):319-20. doi: 10.2215/CJN.10231012. Epub 2012 Nov 15. No abstract available.

21.

Cardiovascular disease in chronic kidney disease: untying the Gordian knot.

Hajhosseiny R, Khavandi K, Goldsmith DJ.

Int J Clin Pract. 2013 Jan;67(1):14-31. doi: 10.1111/j.1742-1241.2012.02954.x. Epub 2012 Jul 11. Review.

PMID:
22780692
22.

Vascular and arterial calcification in peritoneal dialysis patients--state-of-the-art 2012.

Heymann EP, Penny H, Goldsmith DJA.

Contrib Nephrol. 2012;178:189-194. doi: 10.1159/000337851. Epub 2012 May 25. Review.

PMID:
22652736
23.

Dyslipidemia, statins, and CKD patients' outcomes - review of the evidence in the post-sharp era.

Heymann EP, Kassimatis TI, Goldsmith DJ.

J Nephrol. 2012 Jul-Aug;25(4):460-72. doi: 10.5301/jn.5000154. Review.

PMID:
22641572
24.

Investigating FGF-23 concentrations and its relationship with declining renal function in paediatric patients with pre-dialysis CKD Stages 3-5.

Sinha MD, Turner C, Dalton RN, Rasmussen P, Waller S, Booth CJ, Goldsmith DJ.

Nephrol Dial Transplant. 2012 Dec;27(12):4361-8. doi: 10.1093/ndt/gfs109. Epub 2012 Apr 23.

PMID:
22529162
25.

PTH--a particularly tricky hormone: why measure it at all in kidney patients?

Garrett G, Sardiwal S, Lamb EJ, Goldsmith DJ.

Clin J Am Soc Nephrol. 2013 Feb;8(2):299-312. doi: 10.2215/CJN.09580911. Epub 2012 Mar 8. Review.

26.

Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.

Macdougall IC, Roger SD, de Francisco A, Goldsmith DJ, Schellekens H, Ebbers H, Jelkmann W, London G, Casadevall N, Hörl WH, Kemeny DM, Pollock C.

Kidney Int. 2012 Apr;81(8):727-32. doi: 10.1038/ki.2011.500. Epub 2012 Feb 15. Review.

27.

Interrupting the natural history of diabetes mellitus: lifestyle, pharmacological and surgical strategies targeting disease progression.

Khavandi K, Brownrigg J, Hankir M, Sood H, Younis N, Worth J, Greenstein A, Soran H, Wierzbicki A, Goldsmith DJ.

Curr Vasc Pharmacol. 2014 Jan;12(1):155-67. Review.

PMID:
22272898
28.

Parathyroid hormone measurements, guidelines statements and clinical treatments: a real-world cautionary tale.

Garrett G, Goldsmith DJ.

Ann Clin Biochem. 2012 Jan;49(Pt 1):4-6. doi: 10.1258/acb.2011.011254. No abstract available.

PMID:
22218488
29.

The forms and functions of peer social support for people living with HIV.

Peterson JL, Rintamaki LS, Brashers DE, Goldsmith DJ, Neidig JL.

J Assoc Nurses AIDS Care. 2012 Jul-Aug;23(4):294-305. doi: 10.1016/j.jana.2011.08.014. Epub 2011 Nov 13.

30.

Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up.

Sadideen HM, Taylor JD, Goldsmith DJ.

Int Urol Nephrol. 2012 Feb;44(1):275-81. doi: 10.1007/s11255-011-0069-9. Epub 2011 Oct 14.

PMID:
21997202
31.

Significant further evidence to bolster the link between epoetin and strokes in chronic kidney disease and cancer.

Goldsmith DJ, Covic AC.

Kidney Int. 2011 Aug;80(3):237-9. doi: 10.1038/ki.2011.133.

32.

Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers.

Goldsmith DJ, Cunningham J.

Nat Rev Nephrol. 2011 Jun;7(6):341-6. doi: 10.1038/nrneph.2011.53. Epub 2011 May 3. Review.

PMID:
21537350
33.

Association between the malnutrition-inflammation score and post-transplant anaemia.

Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Haromszeki B, Kosa JP, Lakatos P, Beko G, Sarvary E, Varga M, Fornadi K, Novak M, Rosivall L, Kiss I, Remport A, Goldsmith DJ, Kovesdy CP, Mucsi I.

Nephrol Dial Transplant. 2011 Jun;26(6):2000-6. doi: 10.1093/ndt/gfq690. Epub 2010 Nov 29.

PMID:
21115668
34.

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement.

Goldsmith DJ, Covic A, Fouque D, Locatelli F, Olgaard K, Rodriguez M, Spasovski G, Urena P, Zoccali C, London GM, Vanholder R.

Nephrol Dial Transplant. 2010 Dec;25(12):3823-31. doi: 10.1093/ndt/gfq513. Epub 2010 Sep 9. Review.

PMID:
20829401
35.

The incidence of low eGFR and proteinuria in a large tertiary referral lipid clinic.

Davies JB, Crook MA, Wierzbicki AS, Goldsmith DJ.

Int Urol Nephrol. 2011 Sep;43(3):821-5. doi: 10.1007/s11255-010-9819-3. Epub 2010 Aug 13.

PMID:
20706786
36.

Prevalence and management of anaemia in renal transplant recipients: data from ten European centres.

Molnar MZ, Mucsi I, Macdougall IC, Marsh JE, Yaqoob M, Main J, Courtney AE, Fogarty D, Mikhail A, Choukroun G, Short CD, Covic A, Goldsmith DJ.

Nephron Clin Pract. 2011;117(2):c127-34. doi: 10.1159/000319660. Epub 2010 Aug 6.

PMID:
20693814
37.

New hope for chronic kidney disease patients after the JUPITER trial: myth or reality?

Kassimatis TI, Goldsmith DJ.

J Am Coll Cardiol. 2010 Aug 3;56(6):529. doi: 10.1016/j.jacc.2010.04.027. No abstract available.

38.

Sodium thiosulfate: new hope for the treatment of calciphylaxis.

Hayden MR, Goldsmith DJ.

Semin Dial. 2010 May-Jun;23(3):258-62. doi: 10.1111/j.1525-139X.2010.00738.x. Review.

PMID:
20636917
39.

Vascular calcification in chronic kidney disease.

Covic A, Kanbay M, Voroneanu L, Turgut F, Serban DN, Serban IL, Goldsmith DJ.

Clin Sci (Lond). 2010 Apr 28;119(3):111-21. doi: 10.1042/CS20090631. Review.

PMID:
20443781
40.

Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.

Manghat P, Fraser WD, Wierzbicki AS, Fogelman I, Goldsmith DJ, Hampson G.

Osteoporos Int. 2010 Nov;21(11):1853-61. doi: 10.1007/s00198-009-1142-4. Epub 2009 Dec 9.

PMID:
20012018
41.

Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine: a timely reminder of an old foe.

Sangala N, Lee RW, Horsfield C, Goldsmith DJ.

Int Urol Nephrol. 2010 Jun;42(2):503-6. doi: 10.1007/s11255-009-9627-9. Epub 2009 Aug 15. No abstract available.

PMID:
19685279
42.

Blood pressure in dialysis patients-look before we leap.

Goldsmith DJ, Covic A.

Lancet. 2009 Jun 6;373(9679):1945; author reply 1945-6. doi: 10.1016/S0140-6736(09)61061-8. No abstract available.

PMID:
19501738
43.

Meta-analysis of the effects of treating blood pressure on cardiovascular outcomes of dialysis patients.

Goldsmith DJ, Covic AC.

Hypertension. 2009 Jul;54(1):e6; author reply e7. doi: 10.1161/HYPERTENSIONAHA.109.132860. Epub 2009 May 26. No abstract available.

PMID:
19470870
44.

Calcium and the saga of the binders: accumulating controversy, or building consensus?

Goldsmith DJ, Covic A.

Int Urol Nephrol. 2008;40(4):1009-14. doi: 10.1007/s11255-008-9477-x. Epub 2008 Oct 4. Review. No abstract available.

PMID:
18836844
45.

Tuberculosis complicating tertiary hyperparathyroidism in a patient with end-stage renal disease: a case report.

Sadideen HM, Blaker P, O'Donnell P, Taylor J, Goldsmith DJ.

J Nephrol. 2008 May-Jun;21(3):438-41.

PMID:
18587734
46.

Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS).

Cannata-Andía JB, Fernández-Martín JL, Zoccali C, London GM, Locatelli F, Ketteler M, Ferreira A, Covic A, Floege J, Górriz JL, Rutkowski B, Memmos DE, Verbeelen D, Tielemans C, Teplan V, Bos WJ, Nagy J, Kramar R, Goldsmith DJ, Martin PY, Wüthrich RP, Pavlovic D, Benedik M.

J Nephrol. 2008 May-Jun;21(3):290-8.

PMID:
18587716
47.

Nephrotic syndrome in adults.

Hull RP, Goldsmith DJ.

BMJ. 2008 May 24;336(7654):1185-9. doi: 10.1136/bmj.39576.709711.80. Review. No abstract available.

48.

4-pyridone-3-carboxamide ribonucleoside triphosphate accumulating in erythrocytes in end stage renal failure originates from tryptophan metabolism.

Laurence A, Edbury SM, Marinaki AM, Smolenski RT, Goldsmith DJ, Simmonds HA, Carrey EA.

Clin Exp Med. 2007 Dec;7(4):135-41. doi: 10.1007/s10238-007-0137-8. Epub 2008 Jan 11.

PMID:
18188525
49.

Long-term risks of increased use of intravenous iron.

Afzali B, Goldsmith DJ.

Lancet. 2007 Aug 11;370(9586):482; author reply 482-3. No abstract available.

PMID:
17693171
50.

Falls, hypokalaemia, and a dry mouth.

Atalar K, Afzali B, Lams B, Tungekar MF, Goldsmith DJ.

Lancet. 2007 Jul 14;370(9582):192. doi: 10.1016/S0140-6736(07)61093-9. No abstract available.

PMID:
17630043

Supplemental Content

Loading ...
Support Center